The diagnostic potential of salivary protease activities in periodontal health and disease

Abstract

Periodontal disease is characterised by proteolytic processes involving enzymes that are released by host immune cells and periodontal bacteria. These enzymes, when detectable in whole saliva, may serve as valuable diagnostic markers for disease states and progression. Because the substrate specificities of salivary proteases in periodontal health and disease are poorly characterised we probed these activities using several relevant substrates: 1) gelatin and collagen type IV; 2) the Arg/Lys–rich human salivary substrate histatin-5; and 3) a histatin-derived synthetic analog benzyloxycarbonyl-Arg-Gly-Tyr-Arg-methyl cumaryl amide (Z-RGYR-MCA). Substrate degradation was assessed in gel (zymography) and in solution. Whole saliva supernatant enzyme activities directed at gelatin, quantitated from the 42 kDa, 92 kDa and 130 kDa bands in the zymograms, were 1.3, 1.4 and 2.0 fold higher, respectively, in the periodontal patient group (p<0.01), consistent with enhanced activities observed towards collagen type IV. On the other hand, histatin 5 degraded equally fast in healthy and periodontal patients' whole saliva supernatant samples (p>0.10). Likewise, the hydrolysis rates of the Z-RGYR-MCA substrate were the same in the healthy and periodontal patient groups (p>0.10). In conclusion, gelatinolytic/collagenolytic activities but not trypsin-like activities in human saliva differentiate health from periodontal disease, and may thus provide an adjuvant to diagnosis for monitoring of disease activity.

Closing the Border on a New Frontier

“…Thus, the validation of the NGF E max assay for use with saliva (1,3) would have benefited from additional testing, such as cross-checking with other available immunoassays or checks using Western blotting. Admittedly, the fact that that saliva does not contain mature NGF-β, despite the presence of its precursor, is somewhat surprising, as we and others have found that the enzymes required for the splicing of pro-NGF into mature NGF-β (e.g., MMP-2) are abundant in saliva (15).…”

Salivary Peptidomics Targeting Clinical Applications

“…The administration of pilocarpine in adult patients restored the levels of several salivary peptides including a-defensin 1 and b-defensin 2 evaluated by LC-MS using a label-free approach (77). Until now, the majority of studies that analyzed the effect of therapeutic strategies have been focused on salivary proteome, either using gel-based as gel-free approaches (31,76,(84)(85)(86)(87)(88)(89)(90). Regarding the dynamic nature of salivary peptidome, it is time to devote more attention to the comprehension of peptidome adaptation to therapeutics based on peptidomic analysis combined with quantitation strategies.…”

Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics

“…The ease of sampling oral fluids such as saliva and gingival crevicular fluid makes these the preferred biological samples for assessing biomarkers 74. Oral biofilms are also easy for dental professionals to sample, and if chairside tests, such as functional property assays, were available to enable rapid analysis of biofilm samples, this would help guide treatment and therapy.…”